Suchergebnisse - "Pogue, Jason M"

PubPharm (9)

1

Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosa

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Albin, O. | Pogue, J. | Wunderink, R. | +1

2

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP) : a randomised, double-blind, phase 3, non-inferiority trial

enthalten in: The Lancet. Infectious diseases | 2021

von Wunderink, R. | Matsunaga, Y. | Ariyasu, M. | +10

CommentIn: Lancet Infect Dis. 2021 Feb;21(2):153-155. - PMID 33058794

3

Plazomicin : A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections

enthalten in: Drugs | 2019

von Eljaaly, K. | Alharbi, A. | Alshehri, S. | +2

4

Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Pogue, J. | Bonomo, R. | Kaye, K.

5

Averting the post-antibiotic era : successful use of meropenem/vaborbactam for carbapenem-resistant Serratia marcescens and Enterobacter aerogenes bacteraemia in a haemodialysis patient

enthalten in: The Journal of antimicrobial chemotherapy | 2018

von Jorgensen, S. | McDonald, P. | Mynatt, R. | +5

6

Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model

enthalten in: The Journal of antimicrobial chemotherapy | 2018

von Barber, K. | Pogue, J. | Warnock, H. | +2

7

Meropenem-vaborbactam : a new weapon in the war against infections due to resistant Gram-negative bacteria

enthalten in: Future microbiology | 2018

von Patel, T. | Pogue, J. | Mills, J. | +1

8

Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae : pharmacodynamics and morphological changes

enthalten in: International journal of antimicrobial agents | 2017

von Sharma, R. | Patel, S. | Abboud, C. | +6

9

An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase

enthalten in: Antimicrobial agents and chemotherapy | 2016

von Hasassri, M. | Boyce, T. | Norgan, A. | +7

ErratumIn: Antimicrob Agents Chemother. 2016 Aug;60(8):5108. - PMID 27451441

1
[1]